Vanda Pharmaceuticals, Inc. (VNDA)
8.105
+0.18
(+2.21%)
USD |
NASDAQ |
Jan 22, 16:00
8.105
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Research and Development Expense (TTM): 100.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 35.99M |
| Eli Lilly & Co. | 12.56B |
| ADMA Biologics, Inc. | 3.776M |
| Axsome Therapeutics, Inc. | 188.68M |
| AnaptysBio, Inc. | 152.43M |